Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome.
Stevens A, Clayton P, Tatò L, Yoo HW, Rodriguez-Arnao MD, Skorodok J, Ambler GR, Zignani M, Zieschang J, Della Corte G, Destenaves B, Champigneulle A, Raelson J, Chatelain P. Stevens A, et al. Among authors: raelson j. Pharmacogenomics J. 2014 Feb;14(1):54-62. doi: 10.1038/tpj.2013.14. Epub 2013 Apr 9. Pharmacogenomics J. 2014. PMID: 23567489 Free PMC article. Clinical Trial.
Validating genetic markers of response to recombinant human growth hormone in children with growth hormone deficiency and Turner syndrome: the PREDICT validation study.
Stevens A, Murray P, Wojcik J, Raelson J, Koledova E, Chatelain P, Clayton P; PREDICT Investigator Group. Stevens A, et al. Among authors: raelson j. Eur J Endocrinol. 2016 Dec;175(6):633-643. doi: 10.1530/EJE-16-0357. Epub 2016 Sep 20. Eur J Endocrinol. 2016. PMID: 27651465 Free PMC article.
A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome.
Clayton P, Chatelain P, Tatò L, Yoo HW, Ambler GR, Belgorosky A, Quinteiro S, Deal C, Stevens A, Raelson J, Croteau P, Destenaves B, Olivier C. Clayton P, et al. Among authors: raelson j. Eur J Endocrinol. 2013 Jul 29;169(3):277-89. doi: 10.1530/EJE-13-0069. Print 2013 Sep. Eur J Endocrinol. 2013. PMID: 23761422 Free PMC article. Clinical Trial.
Reduced blood pressure after smooth muscle EFNB2 deletion and the potential association of EFNB2 mutation with human hypertension risk.
Wang Y, Hamet P, Thorin E, Tremblay J, Raelson J, Wu Z, Luo H, Jin W, Lavoie JL, Peng J, Marois-Blanchet FC, Tahir MR, Chalmers J, Woodward M, Harrap S, Qi S, Li CY, Wu J. Wang Y, et al. Among authors: raelson j. Eur J Hum Genet. 2016 Dec;24(12):1817-1825. doi: 10.1038/ejhg.2016.105. Epub 2016 Aug 17. Eur J Hum Genet. 2016. PMID: 27530629 Free PMC article.
31 results